American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status…
By E. Winer, C. Hudis, H. Burstein, A. Wolff, K. Pritchard, J. Ingle, R. Chlebowski, R. Gelber, S. Edge, J. Gralow and 12 more. Journal of Clinical Oncology, 2002
1,010 citations recorded by the source corpus.
Subfields: Cancer Research, Endocrinology, Diabetes and Metabolism, Genetics
View Paper: https://www.semanticscholar.org/paper/b099ffebe2f6d65589efd972b229c41a214a9cab
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Genetics
Citations in the corpus
- American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). (2010, background): “Prospective randomized trials have demonstrated that the AIs are slightly more effective than tamoxifen in both the metastatic and adjuvant settings, 38,39 and they are now widely used in both settings.”